I think this part of lastones previous post is key. Alr Technologies is still flying under the radar, an uplisting would give us more exposure and open the stock up to new investors. I think uplisting would be beneficial, but I get your concerns in regards to a reverse split.
"NYSE uses exchanges which opens it up to all investors, funds, analysts, you name it."
I looked up SURG briefly and they did an offering with the IPO along with warrants. They had like 3M shares outstanding and added 4.6M at a discounted price so of course it went down. Not to mention they were not profitable and were losing almost $2M a quarter. ALRT only spent $3M all last year from their 10k and that included all the product development and professional fees relating to it.
If ALRT does a R/S there is no dilution, that is not the same as a R/S and IPO with offering. Also if they are profitable from revenue in Q4 then it is obviously a very different story. Even if they are not profitable because their monthly costs are so low you have to believe they would be close...
News 
Market Data 
Discover 
